Effects of CpG methylation on recognition of DNA by the tumour suppressor p53

Area of Science:

• Molecular Biology
• Epigenetics
• Cancer Research

Background:

• DNA methylation is a key epigenetic mechanism regulating genome expression.
• Aberrant DNA methylation patterns, particularly promoter hypermethylation, are hallmarks of cancer, often silencing tumor suppressor genes.
• CpG dinucleotide methylation within transcription factor binding sites can alter protein-DNA interactions and contribute to oncogenesis.

Purpose of the Study:

• To investigate the impact of CpG methylation on the DNA binding specificity and affinity of the tumor suppressor p53.
• To systematically analyze how methylation at different positions within p53 binding sites affects protein recognition.
• To explore the potential role of altered p53-DNA interactions due to methylation in cancer development.

Main Methods:

• Systematic substitution of CpG dinucleotides within the consensus p53 DNA binding sequence.
• Comparative analysis of methylated versus non-methylated DNA sequences.
• Quantification of p53 binding affinities using fluorescence anisotropy titration.

Main Results:

• Cytosine methylation did not significantly affect p53 binding to the majority of tested DNA sequences.
• For specific sequences, notably those in the RB and Met genes containing multiple CpG sites, methylation led to a 4- to 6-fold increase in p53 binding affinity.
• Identified specific CpG positions where methylation is tolerated or alters p53 binding.

Conclusions:

• CpG methylation has sequence-dependent effects on p53 DNA recognition.
• Increased p53 binding affinity at certain methylated sites may represent a novel regulatory mechanism or a consequence of altered chromatin states in cancer.
• The developed methodology provides a framework for studying the influence of DNA methylation on other DNA-binding proteins and their roles in disease.